Cancer Management and Research
Volume 12, 2020 - Issue
Open access
63
Views
3
CrossRef citations to date
0
Altmetric
Original Research
miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment
Yong Zhang1 Department of Radiology, People’s Hospital of Deyang City, Deyang City, Sichuan Province 618000, People’s Republic of ChinaCorrespondence[email protected]
, Yu-Mei Zhou2 Outpatient Department, People’s Hospital of Deyang City, Deyang City, Sichuan Province, 618000, People’s Republic of China
, Zu-Jian Zhang3 Department of Interventional Radiology, People’s Hospital of Deyang City, Deyang City, Sichuan Province 618000, People’s Republic of China
& Xin Li3 Department of Interventional Radiology, People’s Hospital of Deyang City, Deyang City, Sichuan Province 618000, People’s Republic of China
Pages 9077-9085
|
Published online: 25 Sep 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.